Purchases and Sales Made in Q3 2024 in Prelude Therapeutics Inc (PRLD)
This table provides information about the institutional ownership of Prelude Therapeutics Inc (PRLD) during Q3 2024. The information is specifically focused on institutions that hold shares of Prelude Therapeutics Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-15.5K- 81.06% |
$32.1K - $98.7K
|
3.62K
$4.24K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-16.2K- 51.49% |
$33.5K - $103K
|
15.2K
$17.8K
|
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-18.3K- 14.68% |
$37.9K - $117K
|
106K
$124K
|
|
|
Nov 14, 2024
Q3 2024
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-367K- 8.88% |
$759K - $2.34M
|
3.77M
$4.41M
|
|
|
Nov 14, 2024
Q3 2024
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-860K- 33.49% |
$1.78M - $5.48M
|
1.71M
$2M
|